Psilocybin for depression and anxiety associated with life-threatening illnesses
Carolina Digital Repository (University of North Carolina at Chapel Hill) August 7, 2020 J.d. Mccorvy, R.h.j. Olsen, B.l. Roth
No Summary
Carolina Digital Repository (University of North Carolina at Chapel Hill)
2 papers in the library · publishing 2019-2020
Papers
The Role of Ketamine in Depression
Carolina Digital Repository (University of North Carolina at Chapel Hill) August 16, 2019 Mary S. Garner
Ketamine infusions may provide short-term relief for depressive symptoms, including suicidal ideation, in patients with treatment-resistant depression who have not responded to at least two medication trials. This review examines clinical trials on ketamine for refractory depression, assessing its benefits, limitations, and future potential. Standard therapies for treatment-resistant depression include combination pharmacotherapy, electroconvulsive therapy, transcranial magnetic stimulation, vagal nerve stimulation, and deep brain stimulation.